DraftKings reported Q1 2026 on May 8: revenue +17% YoY to >$1.6B, adj EBITDA +64% to $168M, headline margin +310bps. Stripping Predictions and Arkansas, core margin expanded ≈510bps. April soft close added a forward signal — >$100M adj EBITDA in a single month on +22% revenue and +6% handle, with 15 consecutive weeks of YoY net revenue growth. The stock fell 3.96% to $24.51, about 12% above the $21-22 insider buy zone where CEO Robins, two Directors, and an Officer collectively bought $2.4M in February.

What the filing says

CEO Robins, in Q&A responding to James Hardiman, framed the FY26 guide explicitly: "We were pretty disciplined at the beginning of the year with the guidance... deliberate conservatism... hopefully as the year progresses, raise the guide." The Q4 2025 call had drawn the 2023 parallel directly — that year DKNG guided low, beat every quarter, and finished ≈$300M above the original EBITDA guide. The FY26 guide of $700-900M was reaffirmed; Robins said core (ex-Predictions, ex-Arkansas) is tracking "$1B+ adj EBITDA."

Sportsbook NRM was 7.8% vs the 9%+ exit rate from Q4. The drop is seasonal — Q1 is NBA/NCAAB, Q4 is NFL — not structural. Parlay handle mix continued +300bps YoY; outcomes added "tens of millions"; structural NRM ex-outcomes is ≈7.5-7.7%.

Predictions Q1 spend was minimal; back half is when the $200-300M FY26 investment ramps. April operating data was striking: CAC down 80%+ after integration into the flagship app, annualized consumer volume >$1B (+38% MoM), total volume >$2.3B (+43% MoM). Robins called the market-making layer already profitable — "one of our fastest to profitability business lines we've ever launched." Starting Q2, Sportsbook and Predictions consolidate into a single "Sports Revenue" line — separately-disclosed Predictions revenue disappears.

iCasino growth decelerated to ≈9% from 20%+ in 2025. Robins admitted execution error: DKNG had over-focused on OSB cross-sell instead of slots-first acquisition. A new "Flex Spins" product is the correction.

What the market thinks

Stock $24.51, -35% 1Y (recovered from -53% Feb trough). IV rank 74%, ATM IV 53.5%. Call/Put OI ratio 0.25 (4.1x calls); call IV exceeds put IV by 2.3% — unusual upside skew indicating real bullish flow. $30 call OI 23,992 — the community is pricing $30 as the natural target. The 101-day August expiration prices ≈30% implied move into the Q2 print.

Options-extracted probabilities (extrapolated to 180d): P(stock >$30) ≈30-35%, P(<$20) ≈22-25%, P(<$17.50) ≈8-10%.

Quantitative gap: April's >$100M single-month EBITDA implies $1B+ annualized core run rate against an $800M FY guide midpoint. ≈25% delta between the filing-implied run rate and management's published number. A 180d factor scenario weights raise_and_beat at 45% (E[r] +31.8%), in_line_grind at 35% (E[r] +4.5%), and predictions_drag at 20% (E[r] -18%). Factor E[r] +12.3%; DKNG idio contribution +8.6% at loading 0.7. Probability-weighted 180d target $28.65 (+17%).

Why the gap exists

The print was beat-but-no-raise. Positioning was already long heading in. Profit-taking longs and momentum sellers triggered by the -3.96% move sold; no new buyers. The counterparty is positioning unwind, not informed bear.

Sector inflection is broadly recognized but cross-ticker dispersion isn't synthesized. Q1 2026 cohort: CZR Digital +560bps, RSI +360bps, PENN Interactive +$78M YoY swing, MGM/BetMGM JV +$45M swing, DKNG +310bps headline (+510bps core), FLUT US -300bps margin compression. Six of seven peers confirm the inflection; FLUT is the lone bear outlier — tax pass-through +220bps cost of sales, super PAC G&A +190bps, and a CEO transition (Howe out, Taylor in). The 90-percentage-point DKNG-FLUT US EBITDA growth gap (+64% vs -26%) sits in two transcripts reported two days apart. Most sell-side covers one or the other, not the pair.

Predictions market-making profitability is Day 1 operating data with no precedent in factor models. GENI's public ranking puts category leaders at Kalshi #1 ($14.81B monthly notional), Polymarket #2 ($1.99B), DKNG #3 ($1B+ annualized consumer), FanDuel Predicts #4 (≈$40M Q1 spend). DKNG is ahead of FanDuel in the new category — competitive intelligence not in any sell-side model yet.

Risks (ranked)

1. Predictions investment overrun. $200-300M FY26 envelope is back-half loaded. If Q2 spend exceeds $80M with FanDuel Predicts escalating, core margins compress and the sandbag thesis breaks. Scenario weight 20%.
2. Single-event timing concentration. ≈70% of the alpha resolves at the Q2 print (late July, ≈10 weeks). Options-implied 30% move; IV at 74th percentile.
3. CFTC / state-AG enforcement. Binary tail. Adverse ruling on sports prediction markets kills the Predictions optionality and triggers possible write-down on accumulated investment.
4. Reduced transparency. Sports Revenue consolidation starting Q2 obscures Predictions ROI either direction — masks both deterioration and outperformance.
5. Balance sheet. $1.84B debt + $1.26B converts maturing March 2028. Zero discussion on the Q1 call.
6. iCasino execution. Flex Spins correction is new; share recovery unproven.

Catalysts

• Q2 2026 print, ~late July 2026 — resolves four pending predictions (guide raise ≥$50M, DKNG-FLUT US EBITDA gap ≥20pp, market-making profitability, Sports Revenue consolidation).
• FLUT Q2 print Aug 8-12 — cohort discriminator corroboration.
• NFL season Sept 2026 — NRM normalization back to 9%+.
• Q3 print, early Nov 2026 — modal raise event per 2023 parallel timing.
• Feb 2027 — FY27 guide framing; full sandbag-into-raise resolution.

What would change our mind

• Q2 guide cut by $50M+ → sandbag broken.
• Q2 Predictions spend >$80M (vs minimal Q1) → reinvestment overrun activates.
• Insider Form 4 S-code at $24+ → conviction reversed.
• FLUT US Q2 prints positive EBITDA growth → cohort discriminator weakens; the FanDuel-stalling thesis breaks.
• Stock breaks $20 on volume → below the Feb insider buy floor.
• CFTC or state AG ruling adverse to regulated prediction markets.
• Robins on Q2 call shifts language from "deliberate conservatism" to "we're being prudent given softening demand."

Idio variance is 44.6% — below the 75% target, implying ≈35% IR drag from unhedged factor exposure. The cleanest cohort-discriminator expression is a DKNG/FLUT pair, which isolates the EBITDA divergence but surrenders sector tailwind and carries exposure to an oversold (RSI 25) FLUT. DKNG against BETZ is reflexive — DKNG is 25-30% of BETZ weight.

Evidence